|Last Price||Today's Change||52-Week Range||Trading Volume|
|58.98||4.82 (+8.90%)||46.30 - 59.03||28.3 million (Above Avg)|
Market data as of 4:01PM 10/30/14. Quotes are delayed by at least 15 min.
Bristol-Myers Squibb and Lonza Expand Manufacturing Agreement
10/30/2014 1:00 PM ET
Phase 2 Objective Response Rate and Survival Data for Opdivo (nivolumab) in Heavily Pre-treated Advanced Squamous Cell Non-Small Cell Lung Cancer to be Presented at the 2014 Chicago Multidisciplinary Symposium on Thoracic Oncology
10/30/2014 9:00 AM ET